Curis
CRIS
#11142
Rank
C$3.39 M
Marketcap
C$1.40
Share price
-8.26%
Change (1 day)
-40.31%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): C-$33.22

According to Curis's latest financial reports the company's current EPS (TTM) is C-$33.28. In 2025 the company made an earnings per share (EPS) of C-$33.28 an increase over its 2024 EPS that were of C-$196.59.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$33.22-0.18%
2025C-$33.28-83.07%
2024C-$196.59-22.15%
2023C-$252.51-26.17%
2022C-$342.0022.3%
2021C-$279.64-25.37%
2020C-$374.72-30.93%
2019C-$542.50-2.02%
2018C-$553.69
2016C-$1,258-10%
2015C-$1,398138.1%
2014C-$587.2440%
2013C-$419.46-25%
2012C-$559.2866.67%
2011C-$335.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.83-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.98-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.38-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.96-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$7.05-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$0.24-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA